Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xing Sun

Showing results (401-410 of 418) with videos related to

Pageof 42
Sort By:
Nature Communications|July 25, 2022
Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IRβQian Zhou, Wan-Wan Sun, Jia-Cong Chen, et al.
Theranostics|January 16, 2020
Smooth muscle SIRT1 reprograms endothelial cells to suppress angiogenesis after ischemiaYong-Qing Dou, Peng Kong, Chang-Lin Li, et al.
Protein & Cell|January 3, 2024
Follicle stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulationKai-Hui Zhang, Fei-Fei Zhang, Zhi-Ling Zhang, et al.
Cell Reports. Medicine|March 7, 2026
Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancerTingting Zhang, Wangpeng Cui, Haitao Tang, et al.
The Lancet. Respiratory Medicine|May 8, 2023
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trialShun Lu, Lin Wu, Hong Jian, et al.
Clinical and Experimental Rheumatology|December 11, 2019
Validation of new classification criteria of rheumatoid arthritis in an international multicentre studyRu Li, Xing Sun, Hua Ye, et al.
Cell Reports|March 16, 2022
Methylene-bridge tryptophan fatty acylation regulates PI3K-AKT signaling and glucose uptakeSong-Hua Hu, Xia-Di He, Ji Nie, et al.
The Lancet Regional Health. Western Pacific|September 16, 2021
Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific regionXing Sun, Ru Li, Yueming Cai, et al.
The Lancet. Oncology|July 31, 2022
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trialShun Lu, Lin Wu, Hong Jian, et al.
Cancer Cell|June 28, 2024
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancerCaicun Zhou, Chongyang Li, Libo Luo, et al.
Pageof 42

Showing results (401-410 of 418) with videos related to

Sort By:
Pageof 42
Nature Communications|July 25, 2022
Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IRβQian Zhou, Wan-Wan Sun, Jia-Cong Chen, et al.
Theranostics|January 16, 2020
Smooth muscle SIRT1 reprograms endothelial cells to suppress angiogenesis after ischemiaYong-Qing Dou, Peng Kong, Chang-Lin Li, et al.
Protein & Cell|January 3, 2024
Follicle stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulationKai-Hui Zhang, Fei-Fei Zhang, Zhi-Ling Zhang, et al.
Cell Reports. Medicine|March 7, 2026
Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancerTingting Zhang, Wangpeng Cui, Haitao Tang, et al.
The Lancet. Respiratory Medicine|May 8, 2023
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trialShun Lu, Lin Wu, Hong Jian, et al.
Clinical and Experimental Rheumatology|December 11, 2019
Validation of new classification criteria of rheumatoid arthritis in an international multicentre studyRu Li, Xing Sun, Hua Ye, et al.
Cell Reports|March 16, 2022
Methylene-bridge tryptophan fatty acylation regulates PI3K-AKT signaling and glucose uptakeSong-Hua Hu, Xia-Di He, Ji Nie, et al.
The Lancet Regional Health. Western Pacific|September 16, 2021
Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific regionXing Sun, Ru Li, Yueming Cai, et al.
The Lancet. Oncology|July 31, 2022
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trialShun Lu, Lin Wu, Hong Jian, et al.
Cancer Cell|June 28, 2024
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancerCaicun Zhou, Chongyang Li, Libo Luo, et al.
Pageof 42